Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: Which score to use?

Diseases of the Esophagus

Volumn 19, Issue 5, 2006, Pages 329-334

  Hermann, R M ^a   Horstmann, O ^a   Haller, F ^a   Perske, C ^a   Christiansen, H ^a   Hille, A ^a   Schmidberger, H ^b   Fuzesi L ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Esophageal carcinoma; Histopathological regression grading; Neoadjuvant radiochemotherapy; Prognostic factors

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM;

ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33748701042     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00589.x     Document Type: Article

References (24)

1. Hulscher J B, Tijssen J G, Obertop H, van Lanschot J J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
2. Müller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
3. Hulscher J B F, van Sandick J W, de Boer A G E M et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
4. Geh J I. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-13.
5. Fink U, Stein H J, Wilke H, Roder J D, Siewert J R. Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995; 19: 198-204.
6. Reed C E. Neoadjuvant therapy of esophageal carcinoma. Chest Surg Clin North Am 1994; 4: 299-314.
7. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal acenocarcinoma. N Eng J Med 1996; 335: 462-267.
8. Bosset J F, Gignoux M, Triboulet J P. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Eng J Med 1997; 337: 161-7.
9. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial in preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
10. Bessell J R, Devitt P G, Gill P G, Goya S, Jamieson G G. Prolonged survival follows resection of oesophageal SCC downstaged by prior chemoradiotherapy. Aust N Z J Surg 1996; 66: 214-17.
11. Laterza E, Grisco C, Urso U S et al. Induction therapy for squamous cell carcioma of the thoracic esophagus. Ann Thorac Surg 1994; 57: 1126-32.
12. Bates B A, Detterbeck F C, Bernard S A, Qaqish B F, Tepper J E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-63.
13. Noguchi T, Moriyama H, Wada S et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esoph 2003; 16: 94-8.
14. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-17.
15. Berger A C, Farma J, Scott W J et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-7.
16. Stahl M, Wilke H, Fink U et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-37.
17. Vogel S B, Mendenhall W M, Sombeck M D, Marsh R, Woodward E R. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 685-93.
18. Jones D R, Detterbeck F C, Egan T M, Parker L A Jr, Bernard S A, Tepper J E. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997; 64: 185-91.
19. Brücher B L D M, Stein H J, Zimmermann F et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: Results of a prospective phase-II trial. EJSO 2004; 30: 963-71.
20. Mandard A M, Dalibard F, Mandard J C et al. Pathological assessment of tumor regression after preoperative chemotherapy of esophageal carcinoma. Cancer 1994; 73: 2680-6.
21. Sobin L H, Wittekind Ch, eds. International Union Against Cancer: TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss 2002.
22. Fowler J F, Lindstrom M J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457-67.
23. Dunne B, Reynolds J V, Mulligan E, Kelly A, Griffin M. A pathological study of tumor regression in oesophageal carcinoma treated with preoperative chemoradiotherapy. J Clin Pathol 2001; 54: 841-5.
24. Rohagi P R, Swisher S G, Correa A M et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005; 104: 1349-55.